FDA Inspection 1217681 — Bioindustria Laboratorio Italiano Medicinali S.p.A
The FDA completed an inspection of Bioindustria Laboratorio Italiano Medicinali S.p.A on February 24, 2023 in Novi Ligure. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- February 24, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Novi Ligure (Italy)
Additional Details
Mutual Recognition Agreement (MRA)